Skip to main content

Advertisement

Table 1 Pedacr Response Over Time

From: PReS-FINAL-2161: Safety and effectiveness of adalimumab in children with polyarticular juvenile idiopathic arthritis aged 2 to <4 years or >=4 years weighing <15 kg

  Week 24 Response Rate N = 30 N (%) Week 60 Response Rate N = 20 N (%)
Pedacr 30 27 (90.0) 18 (90.0)
Pedacr 50 25 (83.3) 16 (80.0)
Pedacr 70 22 (73.3) 14 (70.0)
Pedacr 90 11 (36.7) 10 (50.0)